Reporter Oct 3 2014

aspirin pills

Low-dose aspirin’s protective effect in cancer explained

For years, scientists have known that regular aspirin use may reduce the risk of cancer.

HIV cell

Traditional healers contribute to HIV care delays: study

If you’re a native of rural Mozambique who contracts HIV and becomes symptomatic, before seeking clinical testing and treatment, you’ll likely consult a traditional healer.


Team spots key regulator for cholesterol production

A Vanderbilt University-led research team has discovered a “master regulator” for cholesterol production and transport in the liver — a tiny piece of RNA called microRNA-223.

VUSM’s history of diversity efforts commemorated

It has been nearly 50 years since the first black student entered Vanderbilt University School of Medicine (VUSM), and Vanderbilt has come a long way since then.

Program focuses on heart health of cancer patients

The Vanderbilt Cardio-Oncology program has fostered a special collaborative relationship combining the expertise of cardiologists and oncologists to understand the effects of cancer therapy on the heart. This type of collaboration is now helping to define the cardiovascular health of more than 14 million cancer survivors in the United States.

Campaign seeks to bolster biosafety practices

Recent lapses in the handling of highly toxic and pathogenic materials at several federal laboratories have prompted the National Institutes of Health (NIH) to announce a new biosafety stewardship initiative.

1 2